Claim Missing Document
Check
Articles

Found 15 Documents
Search

Information Technology Investment Disclosure, Marketing Efficiency, and Financial Sustainability in Indonesian State-Owned Pharmaceutical Cases Maya Sova; Muhammad Iqbal Ismail
Greenation Computer and Information Review Vol. 2 No. 1 (2025): Greenation Computer and Information Review (October 2025 - March 2026)
Publisher : Greenation Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/gcir.v2i1.864

Abstract

Financial sustainability depends on liquidity and cash generation as well as reported profit, yet technology narratives often omit comparable expenditure and operational return measures. This study examines technology investment disclosure, selling cost efficiency and financial sustainability in Kimia Farma and Phapros through a documentary longitudinal comparison. Public reports provide historical context for 2021–2025 and detailed financial comparisons for 2024–2025. Neither case supplies a consistent, separately identified technology investment series suitable for estimating an investment return. Kimia Farma’s current ratio rises from 0.48 to 0.56 and its operating cash flow margin improves, but its net result remains negative. Phapros’ current ratio rises from 0.95 to 2.29, while operating cash flow decreases despite a revenue rebound and a return to profit. Both selling expense ratios decline, but their compositions and revenue denominators differ. The contribution is a multidimensional reconciliation of commercial cost burden, liquidity and cash generation, with undisclosed technology spending retained as missing. The results show that recovery in one indicator does not establish a general digital investment effect or durable financial sustainability.
Digital Transformation Disclosure, Marketing Intensity, and Financial Performance: Evidence from Indonesian State-Owned Pharmaceutical Cases Denies Susanto; Muhammad Iqbal Ismail
Greenation Computer and Information Review Vol. 2 No. 1 (2025): Greenation Computer and Information Review (October 2025 - March 2026)
Publisher : Greenation Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/gcir.v2i1.865

Abstract

Corporate reports increasingly connect digital transformation with commercial and financial improvement, although disclosed initiatives do not establish their economic contribution. This study examines digital transformation disclosure, selling expense intensity and financial performance in two nested Indonesian state owned pharmaceutical cases. A longitudinal documentary comparison uses public reports covering 2021–2025, with financial comparisons concentrated on the latest comparable figures for 2023–2025. In 2025, Kimia Farma’s selling expense ratio fell from 22.80 to 19.67 percent and its net loss margin narrowed from 12.16 to 4.81 percent despite declining revenue. Phapros’ ratio fell from 49.83 to 30.74 percent, while revenue recovered and its net margin became positive. Both reports describe digital initiatives, but neither provides attribution sufficient to link those initiatives to the financial changes. An exact decomposition shows that lower expenditure and changing revenue denominators contributed differently to the two expense ratios. The contribution is a reproducible distinction between disclosed transformation, selling cost intensity and realised financial outcomes. The findings support a cautious interpretation of annual report based digital measures rather than a causal performance claim.
Market Expansion, Financial Strategy, and Profitability of Indonesian Listed State-Controlled Enterprises Maya Sova; Ani Nuraini; Tiwi Nurhastuti; Muhammad Iqbal Ismail
Greenation Management and Business Review Vol. 3 No. 1 (2026): Greenation Management and Business Review (October 2026 - March 2027)
Publisher : Greenation Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/gmbr.v3i1.808

Abstract

State-controlled enterprises must convert market expansion into sustainable financial performance while balancing commercial and strategic mandates. However, cross-sector evidence on how market growth, financing, and investment jointly relate to profitability in emerging-economy state-controlled firms remains limited. This study examines the associations of revenue growth, financial leverage, and capital expenditure intensity with accounting profitability in 13 Indonesian listed nonfinancial state-controlled enterprises during 2021-2023, producing 39 firm-year observations. Revenue growth represents realized market expansion, while return on assets and operating margin measure profitability. Pooled ordinary least squares models include year effects, asset turnover, and firm-clustered standard errors. Revenue growth is positively associated with both profitability measures, capital expenditure intensity is positive in the baseline models, and leverage is strongly negative for operating margin and for return on assets after distressed firms are excluded. The revenue growth-leverage interaction is not significant. The study's novelty lies in jointly integrating market expansion, financing pressure, and productive investment within a state-ownership setting, showing that these factors operate mainly through additive relationships rather than stable leverage-based moderation.
Digital Transformation Disclosure, Product Innovation, and Market Performance: Financial Evidence from Indonesian State-Owned Pharmaceutical Cases Muhammad Iqbal Ismail; Denies Susanto; Indar Riyanto
Greenation Computer and Information Review Vol. 2 No. 2 (2026): Greenation Computer and Information Review (April - September 2026)
Publisher : Greenation Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/gcir.v2i2.861

Abstract

Digital transformation and product innovation may support pharmaceutical market performance, but research expenditure, product activity and realised sales are different measures. This study examines their reporting relationship in Kimia Farma and Phapros through a longitudinal documentary comparison of public reports covering 2021–2025. The detailed comparison uses 2024–2025 expense and sales information. Kimia Farma’s observed research expense increases from 45.52 to 47.34 billion rupiah after combining separately reported manufacturing and administrative lines, while revenue declines by 7.20 percent. Phapros’ manufacturing research expense decreases from 49.17 to 26.55 billion, while revenue rises by 26.34 percent. In Phapros, ethical and over the counter products account for the largest absolute sales increases, but the report does not isolate revenue generated by newly launched products. Digital narratives describe enabling infrastructure and customer channels rather than measured innovation returns. The contribution is a stage specific measurement framework that separates digital enablement, research input, product launch and commercial conversion. The findings do not identify a causal innovation effect or equate lower research expenditure with lower innovation capability.
Digital Marketing Capability Disclosure, Revenue Growth, and Firm Value: A Longitudinal Study of Indonesian State-Owned Pharmaceutical Cases Muhammad Iqbal Ismail; Denies Susanto; Juhaeri Juhaeri
Greenation Computer and Information Review Vol. 2 No. 1 (2025): Greenation Computer and Information Review (October 2025 - March 2026)
Publisher : Greenation Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/gcir.v2i1.862

Abstract

Digital marketing narratives and improving revenue may appear to imply higher firm value, yet market valuation and book based ratios can move differently. This study examines digital marketing capability disclosure, revenue growth and valuation in Kimia Farma and Phapros through a documentary longitudinal comparison. Public reports provide revenue context for 2021–2025 and comparable market and equity information for 2024–2025. Phapros’ 2025 revenue increased by 26.34 percent, while its reported year end market capitalization declined by 7.41 percent. Kimia Farma’s revenue fell by 7.20 percent and market capitalization declined by 10.74 percent, but its price to parent book equity ratio increased from approximately 0.98 to 1.04 because the book equity denominator contracted faster. Reported digital channels establish customer access arrangements, not a measured marketing capability or a market valuation effect. The contribution is an accounting and market reconciliation that separates commercial recovery, market capitalization and changes in book denominators. The cases demonstrate why a higher valuation multiple cannot automatically be interpreted as value creation from digital marketing.